Advertisement
Asia
Subscribe to Asia

The Lead

West Dedicates Pharmaceutical Manufacturing Plant in India

July 16, 2014 8:41 am | News | Comments

In June 2012, West signed a 99-year lease on 72,800 square meters (approximately 783,600 square feet) of land in Sri City. Sri City offers the advantages of a metropolitan location and was selected primarily on the suitability of land, availability of utilities, labor suitability, logistics and quality of life.

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for...

ScinoPharm President and CEO to Retire

July 11, 2014 8:04 am | News | Comments

ScinoPharm announced that after 17 years of dedicated service, its co-founder and President...

Incyte Get $25M Milestone Payment from Novartis after Jakavi® Approval in Japan

July 8, 2014 9:01 am | News | Comments

Incyte Corporation announced today that it has earned a $25 million milestone payment from...

View Sample

FREE Email Newsletter

Hospira Completes Acquisition of Orchid's API Manufacturing and R&D Facility

July 7, 2014 8:31 am | News | Comments

Hospira has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., an Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza® and Sunvepra® Dual Regimen

July 7, 2014 8:19 am | News | Comments

Bristol-Myers Squibb Company has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Daklinza® (daclatasvir), a potent, pan-genotypic NS5A replication complex inhibitor ( in vitro ), and Sunvepra® (asunaprevir), a NS3/4A protease inhibitor, providing a new treatment that can lead to cure for many patients in Japan who currently have no treatment options.

US Officials Barred from American's Trial in China

July 4, 2014 5:25 am | by The Associated Press | News | Comments

A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.

Advertisement

Pakistan Refugee Crisis Creates Polio Challenge

June 30, 2014 8:50 am | by REBECCA SANTANA, Associated Press; IJAZ MUHAMMED, Associated Press | News | Comments

The rugged Pakistani region of North Waziristan emerged as a hotbed of polio infections after Taliban militants in the isolated area banned immunizations. Now the Pakistani government's offensive against the militants has sent a half-million refugees fleeing the territory, creating both perfect conditions for the disease to spread and a golden opportunity to immunize many thousands of people.

Can Shareholders Stop a Company From Going Global?

June 27, 2014 8:53 am | Videos | Comments

A group of shareholders, led by Yujiro Hara, opposes the hiring of foreign executives at Takeda Pharmaceutical, the biggest drug company in Japan, calling it a “hijacking by foreign capital.”          

More Countries Adding Graphic Warnings to Cigarettes

June 27, 2014 8:08 am | by MARGIE MASON, Associated Press | News | Comments

Indonesia became the newest country to mandate graphic photo warnings on cigarette packs on Tuesday, joining more than 40 other nations or territories that have adopted similar regulations in recent years.        

Abbott to Acquire Russia's Veropharm

June 24, 2014 8:23 am | News | Comments

Abbott has announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Under the terms of the agreement, Abbott will acquire Limited Liability Company Garden Hills, the holding company that currently owns a controlling interest in Veropharm, for between 13.6 billion rubles and 17 billion rubles (or a range of approximately $395 million to $495 million U.S. dollars)

Ex-Novartis Pharma Employee Arrested Over Drug Data

June 11, 2014 8:19 am | News | Comments

Tokyo prosecutors arrested a former employee of Novartis Pharma K.K. on Wednesday on a charge of manipulating clinical study data leading to exaggerated claims in advertising for one of the firm's drugs.        

Advertisement

Manchester United Announces Sponsorship Agreement with Cho-A Pharm

June 9, 2014 8:07 am | News | Comments

Manchester United today announced a multi-year sponsorship deal with Korean Pharmaceutical company Cho-A Pharm to become Manchester United’s Official Pharmaceuticals partner of in South Korea and Vietnam.       

Ranbaxy, Toansa Assessment Concluded - No Risk to Public Health

June 5, 2014 9:14 am | News | Comments

European regulatory authorities have finalized their assessment of reported non-compliance with Good Manufacturing Practice (GMP) at Ranbaxy Laboratories’ manufacturing site in Toansa, India that had led to the suspension of the GMP certificate for the site in the European Union (EU).

Bristol-Myers Squibb and Syngene International Extend Research Collaboration

June 3, 2014 8:18 am | News | Comments

Bristol-Myers Squibb and Syngene International, India’s largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.         

China Fines Eye-Care Companies on Pricing Charges

May 30, 2014 12:33 am | by The Associated Press | News | Comments

China has fined Johnson & Johnson, Nikon and five other foreign makers of eyeglasses and contact lenses on price-fixing charges in its latest effort to use anti-monopoly law to control consumer prices.         

Inside China's Health Care System

May 29, 2014 8:50 am | Videos | Comments

China's state-run health care system is over-stretched and under-funded, creating massive delays.                          

Advertisement

Thirty Percent of World is Now Fat, No Country Immune

May 29, 2014 8:23 am | by MARIA CHENG, AP Medical Writer | News | Comments

Researchers found more than 2 billion people worldwide are now overweight or obese. The highest rates were in the Middle East and North Africa, where nearly 60 percent of men and 65 percent of women are heavy. The U.S. has about 13 percent of the world's fat population, a greater percentage than any other country.

WuXi PharmaTech Begins Operation of New High-Potency API Laboratory

May 28, 2014 8:13 am | News | Comments

WuXi PharmaTech today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical Co., Ltd. (STA), has begun operation of a high-potency active pharmaceutical ingredient (HPAPI) laboratory in Shanghai, thereby adding HPAPI processing to its portfolio of services.

Dainippon Sumitomo Pharma to Stop Trial on New Colon Cancer Drug

May 23, 2014 7:55 am | News | Comments

Dainippon Sumitomo Pharma Co. said today it will effectively stop a clinical trial on a new colon cancer treatment drug it had hoped to start selling in the United States during the year from next April.        

FDA Targets Illegal Online Pharmacies in Globally Coordinated Action

May 22, 2014 1:37 pm | News | Comments

The U.S. Food and Drug Administration, in partnership with other federal and international agencies, took action this week against websites that sell potentially dangerous, unapproved prescription drugs to U.S. consumers.     

Petco to Stop Selling Pet Treats Made in China

May 21, 2014 8:57 am | News | Comments

Investigators at the U.S. Food and Drug Administration haven't been able to figure out why pets are getting ill from the treats since the agency began receiving reports of illnesses in 2007.          

CEO of China Drug Maker Jumps to Death Amid Probe

May 19, 2014 8:35 am | News | Comments

A Chinese drug company says its chief executive has jumped to his death, and official media reported he was under investigation on suspicion of taking bribes.                

Japanese Pharma Employees Inappropriately Involved in Clinical Study

May 16, 2014 8:37 am | News | Comments

Japanese pharmaceutical company Kyowa Hakko Kirin Co. said two of its employees were inappropriately involved in a clinical study on an anemia drug, violating internal rules to secure neutrality.         

British Executive Accused in China Drug Bribery

May 14, 2014 7:57 am | by DIDI TANG, Associated Press | News | Comments

Chinese police have accused a British executive of GlaxoSmithKline of leading a sprawling scheme to bribe doctors and hospitals to use its drugs. The announcement was the first time a foreign employee in China of British-based GSK was accused in the investigation announced last July.

Merck Sells Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific to Santen

May 13, 2014 8:04 am | News | Comments

Santen will make an upfront payment of approximately $600 million and additional payments based on defined sales milestones as needed. The annual sales of these ophthalmology products in the markets within the scope of the agreement are approximately $400 million.

Lannett Announces Multi-Services Agreement with Sunshine Lake LLC

May 12, 2014 7:57 am | News | Comments

Lannett Company announced that it has entered into distribution and contract manufacturing services agreements with Sunshine Lake LLC, the U.S. subsidiary of the HEC Pharm Group (HEC) of Shenzhen, Guangdong Province, China.     

FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access

May 5, 2014 8:14 am | News | Comments

This is the first reported FDA approval of a sterile biologics product manufactured in China for use under a U.S. IND, which marks an important milestone of WuXi's investment to expedite global development of innovative biologics.    

Teva and Takeda to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan

April 28, 2014 8:18 am | News | Comments

Developed by Teva, rasagiline tablets are approved in over 40 countries for the treatment of Parkinson’s disease. Teva developed this product and received its first approval in 2005 in Israel and Europe, and is currently working towards the acquisition of marketing approval of this product in Japan.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading